Structures by: Asik S. I.
Total: 22
6α-Hydroxy-5,6-dihydrosalviasperanol
C20H28O4
Acta Crystallographica Section E (2010) 66, 11 o2899
a=6.2767(2)Å b=11.7358(4)Å c=23.7496(7)Å
α=90.00° β=90.00° γ=90.00°
3-Methyl-5-oxo-4-(2-phenylhydrazinylidene)-4,5-dihydro-1<i>H</i>-pyrazole-1- carbothioamide
C11H11N5OS
Acta Crystallographica Section E (2011) 67, 4 o928
a=7.73880(10)Å b=16.1103(3)Å c=11.3575(2)Å
α=90.00° β=121.0580(10)° γ=90.00°
7-(4-Chlorobenzylidene)-3-[(4-chlorophenoxy)methyl]-6-(4-nitrothiophen-2-yl)- 7<i>H</i>-1,2,4-triazolo[3,4-<i>b</i>][1,3,4]thiadiazine
C22H13Cl2N5O3S2
Acta Crystallographica Section E (2011) 67, 5 o1266-o1267
a=8.5021(2)Å b=10.0379(2)Å c=14.3623(3)Å
α=94.4340(10)° β=97.9810(10)° γ=109.2420(10)°
4-(<i>o</i>-Tolyl)piperazin-1-ium chloride
C11H17N2,Cl
Acta Crystallographica Section E (2011) 67, 11 o3115
a=8.1572(2)Å b=11.2821(3)Å c=12.4256(3)Å
α=90.00° β=90.00° γ=90.00°
4-[(2,4-Difluorophenyl)hydrazinylidene]-3-methyl-5-oxo-4,5-dihydro- 1<i>H</i>-pyrazole-1-carbothioamide
C11H9F2N5OS
Acta Crystallographica Section E (2011) 67, 11 o3116
a=7.90030(10)Å b=8.24000(10)Å c=10.13780(10)Å
α=103.4090(10)° β=99.8640(10)° γ=99.3720(10)°
4-(Morpholin-4-yl)-3-(trifluoromethyl)benzonitrile
C12H11F3N2O
Acta Crystallographica Section E (2011) 67, 7 o1600
a=12.7003(12)Å b=6.8990(7)Å c=13.3484(13)Å
α=90.00° β=91.668(2)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl anthracene-9-carboxylate
C23H15BrO3
Acta Crystallographica Section E (2012) 68, 6 o1876
a=10.1906(8)Å b=15.0591(12)Å c=13.7938(8)Å
α=90.00° β=122.376(4)° γ=90.00°
(1<i>E</i>,2<i>E</i>)-1,2-Bis[1-(3-nitrophenyl)ethylidene]hydrazine
C16H14N4O4
Acta Crystallographica Section E (2012) 68, 3 o643
a=3.9296(3)Å b=7.4448(5)Å c=26.3979(19)Å
α=90.00° β=94.0220(10)° γ=90.00°
Ethyl 2-(4-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1<i>H</i>- benzimidazole-5-carboxylate
C24H27N3O4
Acta Crystallographica Section E (2012) 68, 2 o308-o309
a=10.7455(3)Å b=12.2235(3)Å c=16.1967(4)Å
α=86.1620(10)° β=80.9170(10)° γ=88.2750(10)°
2-(4-Chlorophenyl)-2-oxoethyl 2-methoxybenzoate
C16H13ClO4
Acta Crystallographica Section E (2011) 67, 7 o1687
a=7.7207(6)Å b=14.4411(12)Å c=26.064(2)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-1-(3,4-Dimethoxyphenyl)-3-[4-(methylsulfanyl)phenyl]prop-2-en-1-one
C18H18O3S
Acta Crystallographica Section E (2011) 67, 9 o2403
a=19.0863(7)Å b=19.0863(7)Å c=8.9633(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-[2-(3-methoxyphenyl)hydrazinylidene]-3-oxobutanoate
C13H16N2O4
Acta Crystallographica Section E (2011) 67, 10 o2809
a=5.7796(4)Å b=7.4691(5)Å c=16.9842(11)Å
α=77.956(2)° β=89.394(2)° γ=72.547(2)°
7-Chloro-3-phenylbenzo[4,5]thiazolo[2,3-<i>c</i>][1,2,4]triazole
C14H8ClN3S
Acta Crystallographica Section E (2011) 67, 10 o2810
a=16.9941(13)Å b=5.8895(5)Å c=12.0930(9)Å
α=90.00° β=91.7700(10)° γ=90.00°
4-(3-Chlorophenyl)-3-[(2,6-difluorobenzyl)sulfanyl]-5-(3,4,5- trimethoxyphenyl)-4<i>H</i>-1,2,4-triazole
C24H20ClF2N3O3S
Acta Crystallographica Section E (2011) 67, 12 o3422-o3423
a=9.9867(2)Å b=21.5140(3)Å c=11.9793(2)Å
α=90.00° β=117.1970(10)° γ=90.00°
Ethyl 2-(4-nitrophenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C23H24N4O5
Acta Crystallographica Section E (2012) 68, 1 o59
a=9.31250(10)Å b=10.09410(10)Å c=12.9955(2)Å
α=91.9580(10)° β=107.7520(10)° γ=114.4650(10)°
Ethyl 2-(4-hydroxy-3-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate monohydrate
C24H27N3O5,H2O
Acta Crystallographica Section E (2012) 68, 1 o87-o88
a=9.7460(8)Å b=10.0436(8)Å c=12.6072(10)Å
α=85.7370(10)° β=89.684(2)° γ=70.2380(10)°
Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(1<i>H</i>-imidazol-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C23H22N4O4
Acta Crystallographica Section E (2012) 68, 1 o247-o248
a=15.8554(2)Å b=15.3988(2)Å c=16.2292(2)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C24H25N3O5
Acta Crystallographica Section E (2012) 68, 2 o471-o472
a=11.1692(2)Å b=11.5498(2)Å c=17.4607(3)Å
α=90.00° β=109.2100(10)° γ=90.00°
Ethyl 1-[3-(2-oxopyrrolidin-1-yl)propyl]-2-phenyl-1<i>H</i>- benzimidazole-5-carboxylate
C23H25N3O3
Acta Crystallographica Section E (2012) 68, 2 o251-o252
a=9.9469(3)Å b=10.5845(3)Å c=11.3184(3)Å
α=69.6790(10)° β=67.3740(10)° γ=70.1350(10)°
(<i>E</i>)-1-[4-(Hexyloxy)phenyl]-3-(2-hydroxyphenyl)prop-2-en-1-one
C21H24O3
Acta Crystallographica Section E (2012) 68, 10 o2909
a=7.485(2)Å b=10.834(3)Å c=11.673(3)Å
α=73.858(5)° β=77.961(6)° γ=76.941(6)°
(<i>E</i>)-1-(4-Decyloxyphenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one
C25H32O3
Acta Crystallographica Section E (2012) 68, 10 o2935-o2936
a=8.6674(13)Å b=10.9865(17)Å c=12.1352(19)Å
α=74.405(3)° β=72.891(3)° γ=85.981(4)°
(<i>E</i>)-1-(3-Hydroxyphenyl)-3-[4-(tetradecyloxy)phenyl]prop-2-en-1-one
C29H40O3
Acta Crystallographica Section E (2012) 68, 10 o2911-o2912
a=6.5138(16)Å b=10.155(2)Å c=19.264(5)Å
α=75.361(6)° β=85.872(7)° γ=83.013(6)°